Real-time enrollment status for this immune thrombocytopenia clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 11:03 PM UTC
| NCT Number | NCT06544499 |
| Recruiting Status | Recruiting |
| Condition | Immune Thrombocytopenia |
| Phase | PHASE3 |
| Target Enrollment | 69 participants |
| Active Locations | 18 sites in the US |
| Sponsor | argenx |
| Last Updated on CT.gov | May 1, 2026 (May 1, 2026) |
As of July 17, 2026: Clinical trial NCT06544499 is currently recruiting participants. This phase3 study for immune thrombocytopenia is actively seeking new participants at 18 locations across the United States. The study is sponsored by argenx. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06544499 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06544499 was last updated May 1, 2026 (May 1, 2026). HelloStudys verifies this status automatically.